Promoting INformed Approaches in Precision Oncology and ImmuNoTherapy

Study Overview
=================
Brief Summary
-----------------
The purpose of the research is to: develop an educational website to empower Black and African American cancer patients to make informed decisions about personalized cancer treatment and clinical trials.

Detailed Description
-----------------
The website offers tools for discussing innovative treatments with their clinicians, finding clinical trials, and locating support groups. We are conducting key informant interviews, testing the website with pilot tester and asking volunteers from our Community Advisory Board to review our website prototype to further improve its design and features.

Official Title
-----------------
Promoting INformed Approaches in Precision Oncology and ImmuNoTherapy

Conditions
-----------------
Clinical Trials, Immunotherapy

Intervention / Treatment
-----------------
* Behavioral: PINPOINT Digital Educational Tool


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria for Patient Key Informant: Age 18 and older Self-identify as Black/African American Diagnosed with solid tumor Able to read and speak English fluently Able to provide electronic informed consent Able to complete 2 surveys and an in-depth interview Inclusion Criteria for Relative Key Informant: Age 18 and older Spouse, blood relative, or caregiver of a cancer patient who identifies as Black/African American Able to read and speak English fluently Able to provide electronic informed consent Able to complete 2 surveys and an in-depth interview Inclusion Criteria for Provider Key Informant: Age 18 and older Physician, nurse, social worker, patient navigator, or financial counselor Work in oncology setting Able to read and speak English fluently Able to provide electronic informed consent Able to complete 1 survey and an in-depth interview

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Health Services Research
Intervention Model: Single Group Assignment
Masking: None (Open Label)


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: PINPOINT Digital Educational Tool<br>Newly diagnosed Black cancer patients will be asked to access and engage with the educational website/intervention prototype before their clinic visit or in the clinic immediately before their appointment with their treating oncologist. | Behavioral: PINPOINT Digital Educational Tool<br>* The intervention prototype called the PINPOINT Digital Educational Tool will be comprised of four main sections that include information about: 1) precision oncology; 2) clinical trials; 3) Learn More screens; and 4) discussion points and questions for the treating clinician. The intervention prototype will also include a search function, short videos of patient testimonials, patient-provider interaction about immunotherapy and clinical trials, as well as a list of questions/concerns that the patient could print (or save electronically) and take with them to their provider visit. An optional chatbot will be available in the corner of the screen. Users can ask the chatbot questions about any of the material on the website or request additional information. The chatbot will also be able to help patients search for molecularly targeted and immunotherapy clinical trials and offer additional resources (such as websites and online support groups).<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Community Advisory Board, Key Informants and Pilot Testers | Employ a community-engaged approach, including a Community Advisory Board and key informant interviews, to a) assess knowledge, attitudes, beliefs, and sociocultural, clinical, and system-level factors (e.g., barriers) that may explain disparities in decisions about use of precision oncology in Black cancer patients | June 2021-June 2022 | 
| Website Development | Utilize this information to guide the iterative development and pilot testing of an innovative, patient-centered and culturally tailored internet-based education and decision support intervention, Promoting INformed approaches in Precision Oncology and ImmuNoTherapy (PINPOINT), to reduce racial disparities in access to and use of guideline-based therapy. | June 2021-June 2023 |